Editor's key points † Analysis of uncalibrated arterial pressure waveform is often used to derive cardiac output and stroke volume (SV). † The performances of different models of FloTrac/Vigileo TM during different haemodynamic conditions were reviewed. † The third generation FloTrac/Vigileo TM performed adequately in normo-and hypodynamic conditions but not during hyperdynamic conditions. † SV variability was found to be a reasonable indicator of fluid responsiveness.
window was 10 min. In the 1.07 software version, the window was changed to 1 min. In the 1.10 version, the algorithm was improved to better account for hypertension, tachycardia, and volume loading. The 1.14 version was only an update of the display. The third generation version includes two models for arterial tone: (i) a model that was developed predominantly from patients in normo-and hypodynamic conditions (as in the previous version 1.10) and (ii) a model that was developed predominantly from patients in hyperdynamic conditions. 11 The switching between the two models is based on an algorithm that uses 14 parameters of the arterial pressure waveform to detect the occurrence of hyperdynamic conditions. We hypothesized that the performance of the FloTrac/Vigileo TM to measure CO depends on underlying condition and haemodynamic profile, and on the software version applied. This systematic review summarizes data from clinical studies, analysed to define the current performance of the system in clinical practice and to explore future areas for improvement, as attempted before using 16 early studies. 12 We will systematically review the performance according to commonly used criteria for CO and SVV measurements but will only summarize the findings on the use of the system in therapeutic settings in a narrative way.
Methods
A PubMed literature search on the FloTrac/Vigileo TM system using the headings FloTrac and uncalibrated waveform analysis was performed on the use of the system until May 1, 2013. In total, 139 full manuscripts were found. We excluded animal experimental studies (n¼20), non-English publications (n¼16), non-original manuscripts (n¼8), and the papers from the German group which have been retracted (n¼3). All references of these articles were searched for additional FloTrac articles which yielded an extra 23 manuscripts. One hundred and fifteen manuscripts were included in this review. In 65 papers, CO was compared with a reference standard. The following values were documented: type of patients, underlying clinical condition, software version involved, the mean CO, bias, precision (standard deviation of the bias), percentage (%) error (95% limits of agreement or 2× standard deviation, divided by the mean, according to the Bland -Altman plots), correlation, and concordance with the reference technique if available. The latter is defined by the similarity of direction (in %) or correlation of changes in FloTrac/Vigileo TM and reference method-derived CO. The correlation coefficients are given as coefficients of determination r 2 . The CO was calculated using a body surface area of 1.73 m 2 when only cardiac index was
given. Bias and precision are expressed in litre min 21 in order to facilitate comparison among studies. We have also recalculated other variables, when appropriate and possible from the available data, to standardize the format of reporting. In many studies, horizontal lines in the Bland -Altman plots were drawn for reporting bias, precision, and %error (or 95% limits of agreement) and we extrapolated numbers from these plots if unavailable in the text. Bias was always expressed (or converted if necessary) as the difference between the FloTrac/Vigileo TM and the reference method, so that a negative number indicates underestimation. A 30% error is generally considered acceptable, depending on the error of the reference technique, taken from its reproducibility if solely available. 13 The age and number of patients and paired data were recorded. We did a similar analysis for SVV as far as data were available (n¼8 studies). The quality of the validation studies was rated according to Cecconi and colleagues 14 using the following criteria: the reference technique should be as accurate and precise as possible, for instance, by pulmonary or transpulmonary thermodilution; the precision of the reference technique should be measured within the study; the desired precision of the FloTrac/Vigileo TM technique should be described a priori or thoroughly analysed in the discussion; the bias and limits of agreement between the two techniques should be quoted; and the precision of the new tested technique should be calculated. We evaluated comparisons of radial and other artery pressure-derived CO and evaluated therapeutic studies utilizing the system.
Statistical analysis
We evaluated the factors that may affect system performance of measuring CO. The range of observations and lumping of haemodynamic conditions may confound bias, precision, and %error.
12 15 -18 We therefore evaluated conditions separately and divided patients into three groups accordingly: a group of general critically ill patients including general critically ill or (post)surgical patients with presumably normodynamic conditions, a group of cardiac and (post)cardiac surgery patients with presumably hypodynamic conditions, and a group of patients with liver disease (surgery) or sepsis with hyperdynamic conditions in order to evaluate differences among patient categories and associated haemodynamic states. If data had been obtained in general critically ill patients and the number of patients with sepsis exceeded 50%, we included the respective study in the sepsis category. We constructed tables with relevant variables from the studies and summarized key variables, weighted for patients or data number, by the mean and 95% confidence intervals for the three software generations involved. For concordance, only r 2 was summarized and evaluated. The Kolmogorov -Smirnov test showed that variables were normally distributed (P.0.05). Generalized estimating equations 19 were used to estimate the effect of underlying condition and software version and their first-order interaction on study variables taking repeated measurements into account and adjusted for patient and data numbers. A P-value of ,0.05 was considered statistically significant and exact numbers are given if .0.001.
Results
A total of 65 CO validation studies involved 2234 patients and 44 592 data points. Results are shown in Tables 1-3 . For hypo-and normodynamic conditions, only few data for concordance with third-generation software are available. Adjusted for repeated measurements, patient, and data number, the CO, bias, precision, %error, correlation, and hypo-and normodynamic than in hyperdynamic conditions, even though performance increased with software updates. However, the latest software version most improved performance in hypo-and normodynamic conditions and decreased the %error to 30% or lower. Some studies reported the coefficient of variation for the reference method, ranging between 5% and 18% for intermittent thermodilution, 6 15 20-24 and 2.4% and 6.8% for transpulmonary thermodilution. 7 25 26 The
Cecconi score 14 increased with increasing software version.
For comparison of SVV with other dynamic indices, eight studies (n¼291 patients and n¼935 data) were available (Table 5 ), but evaluation of the effect of patient and software types was not considered meaningful because of paucity of data. The table shows moderate agreement of FloTrac/Vigileo TM SVV with other dynamic indices.
Discussion
The last 9 yr have witnessed an exponential increase in clinical research on the application of the FloTrac/Vigileo TM system and this systematic review was intended to identify areas for routine clinical use and for future development. Our analysis is useful, even though older software will not be used anymore, by displaying the capability to improve the performance of this less invasive CO measurement technique. Indeed, the accuracy and precision of the FloTrac/Vigileo TM system can be regarded as sufficient for routine clinical use in hypo-or normodynamic conditions in the absence of large changes in vascular tone. The performance of the system in hyperdynamic conditions, even with the latest software version, is still inadequate as our systemic review suggests. Even though SVV may not perfectly agree with that obtained by other means, it is useful in predicting fluid responsiveness.
We will now illustrate that our systematic review is limited by the heterogeneity of the included studies, so that conclusions should be drawn cautiously. An unconventional reference method was used in one study of general critically ill and surgical patients (Table 1) , 18 since SV derived from the FloTrac/Vigileo TM was compared with SV determined with the help of two oesophageal Doppler probes, a technique that is operatordependent. In comparing FloTrac/Vigileo TM with transthoracic Doppler during induction of anaesthesia and intubation in patients undergoing abdominal aortic reconstruction, 35 increases in arterial pressure led to an overestimation of CO by FloTrac/Vigileo TM . On the other hand, second-and even third-generation software resulted in underestimation of CO during vasodilation in patients with intracranial haemorrhage. 25 36 The second-generation software may not suffice to monitor prone positioning of patients with acute respiratory distress syndrome. 37 In cardiac (surgical) patients (Table 2) , the accuracy of FloTrac/Vigileo TM -derived CO was limited by arrhythmias, alterations in the arterial pressure waveform in aortic stenosis and insufficiency and during intra-aortic balloon pumping. 38 However, a good correlation between FloTrac/Vigileo TM and thermodilution CO was documented 15 reported a concordance of 59% with intermittent thermodilution-derived CO for changes ,15% in a mixed patient population. These changes may be too small to be clinically relevant. However, the FloTrac/Vigileo TM failed to detect an increase in transpulmonary thermodilution CO of 15% or greater after fluid challenges and use of norepinephrine in septic patients. 26 With the use of the most recent software, the same group reported slightly improved performance, but with better concordance with transpulmonary thermodilution for CO changes during fluid loading than norepinephrine administration in septic patients. 60 We 51 52 compared software versions 1.07, 1.10, and 3.02 with intermittent thermodilution CO in the treatment of septic shock and showed good tracking ability during the course of treatment of the syndrome. Dobutamine treatment of subarachnoid haemorrhage patients with delayed cerebral ischaemia resulted in an error of only 15% when comparing FloTrac/Vigileo TM with transpulmonary thermodilution CO, at an unaltered vascular tone. 67 Otherwise, we did not individually assess the interventions for reporting concordance. In contrast to CO measurements, the sampling site may not affect SVVs. 68 There were eight comparative studies of SVV measurements (Table 5 78 the increase in SVV with removal of blood and the decrease with replacement by colloids were predictive of the course of CO and echocardiography-determined left ventricular end-diastolic volume. The SVV derived from FloTrac/Vigileo TM predicted, and also PP variation, a decrease in SV (thermodilution and FloTrac/Vigileo TM ) induced by positive end-expiratory pressure. 88 After oesophageal surgery, 77 89 FloTrac/Vigileo TM -derived SVV may be a useful parameter to predict hypovolaemia and fluid responsiveness. Only few studies failed to validate the usefulness of FloTrac/ Vigileo TM -derived SVV to predict fluid responsiveness. 59 90 -92 Echocardiography-derived variations in vena cava inferior diameter predicted fluid responsiveness in fully mechanically ventilated, mostly septic, critically ill patients, but the FloTrac/ Vigileo TM -derived SVV did not. 59 In patients undergoing liver surgery or pneumoperitoneum for laparoscopic surgery, FloTrac/Vigileo TM -derived SVV appeared less useful, 90 92 whereas oesophageal Doppler-derived SV was used as a reference standard, even though its reproducibility is operatordependent. 28 -30 Obviously, the validity of SVV as a predictor of fluid responsiveness is subject to some conditions, including a regular cardiac rhythm, absence of right ventricular overloading, and others. Recommendations for comparison of haemodynamic monitoring devices 14 have rarely been fully followed. 61 Otherwise, the dependency of bias on vascular resistance implies a systematic error which results in (and can be inferred from) a significant relation between differences and means with the reference technique. Even when clear from the Bland -Altman plots provided, this has rarely been objectively evaluated or accounted for. 41 51 Conversely, the % (random) error may be overestimated when data are pooled on repeated measurements of patients with differences in vascular tone and thus in systematic error. Finally, none of the studies directly compared software versions in the same patients; in some studies, the version was not reported. Our study does not provide an answer to the question whether this technology should be used or not; it merely demonstrates that system performance has positively evolved over the years, allowing its routine use in specific conditions. In conclusion, the performance of uncalibrated FloTrac/Vigileo TM has improved since its introduction, particularly in hypoand normodynamic conditions. Since the average %error is below 30%, the CO measured with help of most recent software may be sufficiently accurate for routine clinical use in these conditions, even though trending capacity remains affected by changes in vascular tone. The SVV may usefully supplement these measurements, particularly in future outcome studies.
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